OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 21 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $553,000 | -17.2% | 579,126 | -0.3% | 0.32% | -19.0% |
| Q4 2015 | $668,000 | +1032.2% | 581,126 | +2929.2% | 0.39% | +1613.0% |
| Q2 2014 | $59,000 | -92.0% | 19,184 | -90.2% | 0.02% | -92.7% |
| Q1 2014 | $742,000 | +4.8% | 196,685 | -3.6% | 0.31% | +6.4% |
| Q4 2013 | $708,000 | +13.6% | 204,111 | -10.3% | 0.30% | +6.9% |
| Q3 2013 | $623,000 | +258.0% | 227,461 | +236.4% | 0.28% | +240.7% |
| Q2 2013 | $174,000 | – | 67,611 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|